Celldex Therapeutics, Inc. - Company Profile and SWOT Analysis
SummaryCelldex Therapeutics, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Celldex Therapeutics, Inc. (Celldex or 'the company') is a biopharmaceutical company that develops therapeutic monoclonal and bispecific antibodies for the treatment of inadequate diseases. The company is involved with human immune system which improves inflammatory diseases and many forms of cancer. It also develops therapies for patients with unmet medical needs. The company's major products in development include barzolvolimab CDX-0159 and CDX-622. It operates research laboratories in New Jersey, Massachusetts and Connecticut, the US. Celldex operates cGMP manufacturing facility in Fall River, Massachusetts, the US to produce drug substances for current and planned early-stage clinical trials. The company is headquartered in Hampton, New Jersey, the US.
Scope
Celldex Therapeutics, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Celldex Therapeutics, Inc. (Celldex or 'the company') is a biopharmaceutical company that develops therapeutic monoclonal and bispecific antibodies for the treatment of inadequate diseases. The company is involved with human immune system which improves inflammatory diseases and many forms of cancer. It also develops therapies for patients with unmet medical needs. The company's major products in development include barzolvolimab CDX-0159 and CDX-622. It operates research laboratories in New Jersey, Massachusetts and Connecticut, the US. Celldex operates cGMP manufacturing facility in Fall River, Massachusetts, the US to produce drug substances for current and planned early-stage clinical trials. The company is headquartered in Hampton, New Jersey, the US.
Reasons To Buy
- Detailed information on Celldex Therapeutics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Celldex Therapeutics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Celldex Therapeutics, Inc. including a breakdown and examination of key business segments
- Intelligence on Celldex Therapeutics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Celldex Therapeutics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.